Marisa Dolled Filhart
About Marisa Dolled Filhart
Marisa Dolled Filhart is the Vice President of Translational Research, Cell Therapy and Cancer Immunology TRC at Bristol Myers Squibb and serves on the board of the Yale Graduate School Alumni Association.
Current Roles at Yale University and Bristol Myers Squibb
Marisa Dolled Filhart currently serves as a Board Member of the Yale Graduate School Alumni Association in New Haven, Connecticut. Concurrently, she holds the position of Vice President of Translational Research, Cell Therapy, and Cancer Immunology TRC at Bristol Myers Squibb. Her roles encompass significant responsibilities in advancing research and strategic initiatives within these respected institutions.
Past Leadership Roles at Bristol Myers Squibb and Merck
Before her current position, Marisa Dolled Filhart was the Head of Translational Development, Tumor Microenvironment TRC at Bristol Myers Squibb from 2020 to 2022. Her career at Merck included several high-level roles: Executive Director, Oncology Global Medical Affairs, Biomarkers and Diagnostics (2019-2020); Sr. Director, Regulatory Liaison, Oncology and IVD/CDx (2018-2019); and Global Commercial Biomarker Strategy, Oncology Global Marketing (2016-2018). She also served as Sr. Director of Pathology & Companion Diagnostics, Translational Biomarkers (2015-2016) and Director, Molecular Biomarkers and Diagnostics (2012-2015).
Educational Background
Marisa Dolled Filhart holds a Ph.D. in Genetics from Yale University, completed between 2000 and 2005. Additionally, she earned a B.A. in Biology from Cornell University from 1996 to 2000. She also pursued executive education programs at Harvard Business School, The Wharton School, and Simmons University, focusing on leadership and management within the pharmaceutical industry.
Diverse Experience in Oncology and Strategic Alliances
Marisa Dolled Filhart's professional journey includes strategic positions at organizations such as Rare Genomics Institute and HistoRx, Inc. At Rare Genomics Institute, she worked on strategic alliances, and at HistoRx, she advanced from Technical Manager in Business Development to Group Leader in R&D and later served as Senior Director of Pharma Services. Early in her career, she interned at the Coriell Institute for Medical Research.
Recognition and Board Memberships
Marisa Dolled Filhart received the 2024 HBA Luminary Award, acknowledging her outstanding contributions to the healthcare industry. Since July 2023, she has been a board member of the Yale Graduate School Alumni Association, where she continues to support and engage with the academic community.